Recent Research and Innovations in Oncology


Continuous malignant tumor drug discovery and development is vital to seek out an entire cure for cancer. Because of the drug resistance developed by tumor cells for existing treatments, this is often changing into a compulsory approach to fight the illness.



• Scientific investigations on inhibitors of stop CHK1 will be another milestone for antineoplastic drug discovery approach.



• Cancer cells are specifically dependent on molecular chaperones and related proteins that regulate homeostasis. These are promising targets for new anticancer therapies.



• Deregulated necrobiosis is hallmark of cancer and Bcl-2 family of proteins are crucial to mediating the pathway of this method. Inhibiting their method may be a big approach for developing new malignant tumor medication. Several plant sources are noted to be valuable sources of novel anti-cancer properties.


    Related Conference of Recent Research and Innovations in Oncology

    July 14-15, 2025

    5th World Congress on Breast Cancer

    Berlin, Germany
    July 28-29, 2025

    45th Euro Congress on Cancer Science & Therapy

    Paris, France
    August 18-19, 2025

    6th Cancer Diagnostics & Treatment Conference

    Rome, Italy
    October 20-21, 2025

    21st International Conference on Cancer Research

    Barcelona, Spain
    October 22-23, 2025

    35th Experts Meet On Cancer Research & Therapy

    Paris, France
    October 24-25, 2025

    25th World Congress on Cancer and Diagnostics

    Zurich, Switzerland
    November 20-21, 2025

    26th World Congress on Cancer Summit

    Amsterdam, Netherlands
    November 24-25, 2025

    43rd World Cancer Conference

    Barcelona, Spain
    March 23-24, 2026

    16th World Congress on Breast Cancer Research & Therapies

    Aix-en-Provence, France

    Recent Research and Innovations in Oncology Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in